Skip to content

The Effect of Dark Chocolate Consumption on Blood Parameters in Healthy Adult Individuals

The Effect of Dark Chocolate Consumption on Blood Parameters in Healthy Adult Individuals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05290012
Enrollment
37
Registered
2022-03-22
Start date
2020-12-20
Completion date
2021-03-17
Last updated
2022-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Keywords

Chocolate, Cacao, Cholesterol, Blood Glucose, Blood Pressure

Brief summary

In healthy individuals, the effect of regular dark chocolate consumption for 4 weeks on blood lipid parameters such as; total cholesterol, LDL cholesterol, HDL cholesterol and triglyceride levels, in addition to fasting blood glucose, HbA1c, CRP levels and blood pressure was investigated.

Detailed description

Recent studies have shown that dark chocolate consumption may have a positive effect on cardiovascular risk markers.The aim of this study is to investigate the effect of regular consumption of dark chocolate (36 g/day) on biochemical blood parameters in healthy individuals. A total of 37 healthy individuals completed the study conducted in this direction. Participants were randomly divided into two groups as dark chocolate group (n=17) and control group (n=20). While the dark chocolate group consumed 36 g/day (400 mg/day flavanol) dark chocolate for 4 weeks, the control group did not receive any intervention. At the end of the study, the anthropometric measurements of the individuals were evaluated. Blood lipid profile, fasting blood glucose, HbA1c, CRP levels, systolic blood pressure and diastolic blood pressure measurements were investigated.

Interventions

OTHERDark Chocolate

A daily consumption of 36 g dark chocolate (400 mg/day flavanol) was made. No Cocoa/chocolate product was consumed other than the intervention product.

Sponsors

Eastern Mediterranean University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \< 30 kg/m2 * Systolic blood pressure \<140 mmHg and/or diastolic blood pressure \<90 mmHg

Exclusion criteria

* Individuals with any diagnosed chronic or acute illness * Individuals diagnosed or in contact with Covid-19 * Individuals with allergies to cocoa/chocolate products * Individuals in the process of losing weight * Individuals with smoking and alcohol consumption * Individuals taking medication or vitamin/mineral supplements * Individuals doing heavy physical activity * Individuals who regularly consume cocoa/chocolate products for the last 1 month (\> 3 days a week) * Pregnant or lactating women were excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Change in blood pressure from baseline with dark chocolate consumption at week 4.Baseline and Week 4At the beginning and end of the study, the blood pressure (systolic blood pressure and diastolic blood pressure) measurements of the individuals were measured with the Nimo LD-520 digital blood pressure device. Change = (Baseline blood pressure-Week 4 blood pressure)
Change in serum lipid levels from baseline with dark chocolate consumption at 4 weeks.Baseline and Week 4Serum lipid levels (total cholesterol, LDL cholesterol, HDL cholesterol and triglyceride) were measured by taking blood samples from individuals at the beginning and end of the study. Differences in blood lipid variables were analyzed using the Statistical Package for Social Sciences (SPSS) 24.0 program. Change = (Baseline serum lipid levels-Week 4 serum lipid levels)
Change in glycemic parameters from baseline with dark chocolate consumption at 4 weeks.Baseline and Week 4At the beginning and end of the study, blood samples were taken from the individuals and their HbA1c and fasting blood glucose levels were measured. Differences in glycemic variables were analyzed using the Statistical Package for Social Sciences (SPSS) 24.0 program. Change = (Baseline glycemic parameters-Week 4 glycemic parameters)
Change in CRP levels from baseline with dark chocolate consumption at 4 weeks.Baseline and Week 4At the beginning and end of the study, blood samples were taken from the individuals and their CRP (C-reactive protein) levels were measured. Differences in the CRP variable were analyzed using the Statistical Package for Social Sciences (SPSS) 24.0 program. Change = (Baseline CRP levels-Week 4 CRP levels)

Secondary

MeasureTime frameDescription
Change in body weight from baseline with dark chocolate consumption at week 4.Baseline and Week 4The body weight (kg) of the subjects was measured at the beginning and end of the study. The measurement was made with Tanita-BC-601. Change = (Baseline body weight-Week 4 body weight)
Change in BMI from baseline with dark chocolate consumption at week 4.Baseline and Week 4The body mass index (BMI) of individuals at the beginning and end of the study was measured using mathematical calculation (weight/height squared; in kilograms per square metre).Change = (Baseline BMI-Week 4 BMI)
Change in body fat percentage from baseline with dark chocolate consumption at week 4.Baseline and Week 4Body fat percentage (%) of individuals was measured at the beginning and end of the study. The measurement was made with Tanita BC-601. Change = (Baseline body fat percentage-Week 4 body fat percentage)
Change in waist circumference from baseline with dark chocolate consumption at week 4.Baseline and Week 4At the beginning and end of the study, the waist circumference (cm) of the individuals (midway between the rib cage and the iliac crest) was measured using a flexible tape measure. Change = (Baseline waist circumference-Week 4 waist circumference)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026